MetLife Investment Management’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $283K | Hold |
4,733
| – | – | ﹤0.01% | 1990 |
|
|
2025
Q1 | $248K | Sell |
4,733
-112
| -2% | -$5.88K | ﹤0.01% | 2082 |
|
|
2024
Q4 | $266K | Buy |
4,845
+494
| +11% | +$27.2K | ﹤0.01% | 2150 |
|
|
2024
Q3 | $219K | Hold |
4,351
| – | – | ﹤0.01% | 2242 |
|
|
2024
Q2 | $191K | Buy |
4,351
+465
| +12% | +$20.4K | ﹤0.01% | 2271 |
|
|
2024
Q1 | $171K | Hold |
3,886
| – | – | ﹤0.01% | 2279 |
|
|
2023
Q4 | $184K | Hold |
3,886
| – | – | ﹤0.01% | 2283 |
|
|
2023
Q3 | $172K | Hold |
3,886
| – | – | ﹤0.01% | 2293 |
|
|
2023
Q2 | $186K | Hold |
3,886
| – | – | ﹤0.01% | 2326 |
|
|
2023
Q1 | $153K | Hold |
3,886
| – | – | ﹤0.01% | 2373 |
|
|
2022
Q4 | $110K | Hold |
3,886
| – | – | ﹤0.01% | 2558 |
|
|
2022
Q3 | $117K | Hold |
3,886
| – | – | ﹤0.01% | 2598 |
|
|
2022
Q2 | $132K | Hold |
3,886
| – | – | ﹤0.01% | 2573 |
|
|
2022
Q1 | $174K | Buy |
3,886
+1,395
| +56% | +$62.6K | ﹤0.01% | 2440 |
|
|
2021
Q4 | $115K | Buy |
+2,491
| New | +$115K | ﹤0.01% | 2361 |
|